Alder Biopharmaceuticals

Pharmaceuticals & Biotech

Alder Biopharmaceuticals Careers, Pay and Expert Network

lightbulbWhat are the highest paying jobs at Alder Biopharmaceuticals?

Alder Biopharmaceuticals is a pharmaceutical development company based in Bothell, Washington. Alder specializes in therapeutic monoclonal antibodies. The company was founded by Randall C. Schatzman, John A. Latham, and Mark J. Litton in 2004. The CEO is Dr. Randy Schatzman. Alder went public in May 2014. Their best known drug is the monoclonal antibody eptinezumab, which is now in its second phase III trial for migraine prevention. They have a second monoclonal antibody drug for migraine, ALD-1910, currently in phase II clinical trials. Alder licensed clazakizumab, previously ALD-518, an anti-IL-6 monoclonal antibody to Vitaeris, Inc. for worldwide marketing.

Snapshot

Employees484
Market Cap$368.3 million
Revenue$10.4 million
Net Income-$10.3 million
NASDALDR
Founded2004
Annual Report
Total value of jobs:
$3,240,000
Average Pay:
$124,615
Total Experts:
1
% Masters:
17%

Top Experts at Alder Biopharmaceuticals

Alder Biopharmaceuticals Salaries

Account Manager

$125K

$125K

Average Salary:$125,000

View All Salaries